DiaMedica Therapeutics Inc. (DMAC) Tops Q2 EPS by 3c

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) reported Q2 EPS of ($0.13), $0.03 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on DiaMedica Therapeutics Inc. (DMAC) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• FuelCell Energy (FCEL) call put ratio 1 call to 1 put into quarter results